14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $110.93 Friday, 3rd May 2024 BPMC stock ended at $107.19. This is 0.178% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.50% from a day low at $106.15 to a day high of $110.93.
90 days $72.25 $110.93
52 weeks $43.89 $110.93

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
May 05, 2023 $59.29 $59.34 $55.86 $56.23 873 981
May 04, 2023 $51.09 $60.00 $51.09 $58.41 1 396 228
May 03, 2023 $50.43 $52.95 $50.04 $51.88 612 578
May 02, 2023 $51.56 $51.67 $49.81 $49.89 599 365
May 01, 2023 $51.28 $52.80 $51.05 $51.50 656 620
Apr 28, 2023 $48.33 $51.14 $47.42 $51.05 501 469
Apr 27, 2023 $49.21 $49.30 $48.21 $48.62 448 409
Apr 26, 2023 $48.99 $49.24 $47.89 $49.02 370 324
Apr 25, 2023 $47.56 $48.94 $47.56 $48.85 464 659
Apr 24, 2023 $48.82 $49.05 $47.95 $48.05 364 716
Apr 21, 2023 $48.35 $49.54 $47.86 $49.05 360 146
Apr 20, 2023 $47.80 $48.64 $47.37 $48.16 316 791
Apr 19, 2023 $48.57 $49.80 $48.33 $48.46 485 014
Apr 18, 2023 $48.62 $48.99 $47.38 $48.96 579 124
Apr 17, 2023 $47.36 $48.97 $46.99 $48.27 563 536
Apr 14, 2023 $46.82 $47.38 $45.97 $46.86 389 705
Apr 13, 2023 $44.00 $47.49 $44.00 $46.95 498 363
Apr 12, 2023 $44.86 $45.23 $43.49 $43.80 274 301
Apr 11, 2023 $42.38 $44.47 $42.26 $44.19 423 225
Apr 10, 2023 $43.54 $43.54 $41.75 $42.38 356 260
Apr 06, 2023 $42.57 $43.97 $41.78 $43.83 382 365
Apr 05, 2023 $42.10 $42.86 $41.54 $42.39 719 713
Apr 04, 2023 $44.62 $44.63 $41.59 $42.20 790 596
Apr 03, 2023 $44.75 $45.96 $44.23 $44.52 415 228
Mar 31, 2023 $44.66 $45.74 $44.32 $44.99 470 742
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT